 |
|
Treatment of rocuronium-induced anaphylaxis using sugammadex - A case report -
Sun-Min Kim, Sei-hoon Oh, Seung-Ah Ryu
Anesth Pain Med. 2021;16(1):56-59. Published online 2020 Dec 17 DOI: https://doi.org/10.17085/apm.20074
|
|
Citations to this article as recorded by
 Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo
Alice Dejoux, Qianqian Zhu, Adam Woolfe, Ophélie Godon, Sami Ellouze, Guillaume Mottet, Carlos Castrillon, Caitlin Gillis, Cyprien Pecalvel, Christelle Ganneau, Bruno Iannascoli, Frédéric Lemoine, Frederick Saul, Patrick England, Laurent L. Reber, Aurélie
Journal of Allergy and Clinical Immunology.2025; 155(5): 1557. CrossRef RETRACTED: Efficacy and safety of sugammadex sodium in reversing rocuronium-induced neuromuscular blockade in children: An updated systematic review and meta-analysis
Sheng Zhou, Haiying Hu, Jianfen Ru
Heliyon.2023; 9(8): e18356. CrossRef Biologics to treat anaphylaxis
Barbara C. Yang
Current Opinion in Allergy & Clinical Immunology.2023; 23(5): 370. CrossRef Role of sugammadex in the treatment of anaphylaxis due to rocuronium in children: Extrapolation from adult and animal reports
Anuranjan Ghimire, Vanessa A. Olbrecht, Joseph D. Tobias
Pediatric Anesthesia.2022; 32(6): 706. CrossRef Perioperative anaphylaxis caused by muscle relaxants: Do we know enough?
Danica Marković, Natalija Vuković, Jelena Milenković, Bojana Marković-Živković, Ivana Budić
Srpski medicinski casopis Lekarske komore.2022; 3(4): 462. CrossRef
|